Table: begin end state 1 24 cytoplasmic 25 46 transmembrane 47 51 non-cytoplasmic 52 73 transmembrane 74 91 cytoplasmic 92 113 transmembrane 114 132 non-cytoplasmic 133 154 transmembrane 155 164 cytoplasmic 165 185 transmembrane 186 204 non-cytoplasmic 205 225 transmembrane 226 249 cytoplasmic 250 271 transmembrane 272 295 non-cytoplasmic 296 321 transmembrane 322 340 cytoplasmic 341 362 transmembrane 363 367 non-cytoplasmic 368 391 transmembrane 392 411 cytoplasmic 412 434 transmembrane 435 439 non-cytoplasmic 440 459 transmembrane 460 474 cytoplasmic
Input: >PfGW456L13_3211 MNENTDRSTDHKGIQLTRALKSRHIFMLSLGGVIGTGLFMGSGVTINQGGPVGAILAYLV AGFLMYLVMVCLGELSVQMPVSGSFQTHATKYIGPATGFMIGWVYWMSWATTVGLEFTAA GMLMTRWFPEVPIWYWSALFVVVLFGINAMATRAFGEAEYWFSGIKVAAILGFIVVGVLV IFGVMPLSSGAPAPMATNLIGDSLFPNGLSAVFAVMMTVVYAFQGCEIMGVAAGETDQPE KSIPRAVRNVVFRVLIFYVLAIIVLSAIVPWQQAGLMESPFVQVFDMVGIPYAADLMNFV ILTAILSVGNSGLYASTRILWAMSKTGMAPKSLSPLSKRGVPLRALSITLCFALVSLMTS FVAADTLFMVLMAVSGMSGTVTWIVIALAQYKFRKAYLRDGGKLRDLKYRAPWFPVLPLM CITLCCSLFVFLALDETQRPSLYWGFGFIALCYGAYFLIHRKRGAVLAPSLPAA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server